PAGAN, ELEONORA
 Distribuzione geografica
Continente #
NA - Nord America 5.215
AS - Asia 4.936
EU - Europa 3.197
SA - Sud America 656
Continente sconosciuto - Info sul continente non disponibili 432
AF - Africa 105
OC - Oceania 18
Totale 14.559
Nazione #
US - Stati Uniti d'America 4.905
SG - Singapore 1.563
VN - Vietnam 1.166
IT - Italia 1.121
CN - Cina 733
DE - Germania 640
HK - Hong Kong 632
BR - Brasile 492
RU - Federazione Russa 426
CA - Canada 253
SE - Svezia 252
BD - Bangladesh 209
IE - Irlanda 179
FR - Francia 157
IN - India 138
ID - Indonesia 105
GB - Regno Unito 95
KR - Corea 70
AR - Argentina 67
FI - Finlandia 58
JP - Giappone 43
TR - Turchia 43
NL - Olanda 42
UA - Ucraina 39
PK - Pakistan 35
IQ - Iraq 34
AT - Austria 30
ZA - Sudafrica 30
EC - Ecuador 27
ES - Italia 26
MX - Messico 26
PL - Polonia 24
CH - Svizzera 23
DK - Danimarca 23
SA - Arabia Saudita 23
CO - Colombia 21
PH - Filippine 20
IR - Iran 17
AU - Australia 15
PY - Paraguay 14
TN - Tunisia 14
MY - Malesia 13
ET - Etiopia 12
RO - Romania 11
CL - Cile 9
EG - Egitto 9
KE - Kenya 9
LB - Libano 9
PE - Perù 9
TW - Taiwan 9
UZ - Uzbekistan 9
BG - Bulgaria 8
CZ - Repubblica Ceca 8
JM - Giamaica 8
TH - Thailandia 8
VE - Venezuela 8
AE - Emirati Arabi Uniti 7
GR - Grecia 7
MA - Marocco 7
BO - Bolivia 6
IL - Israele 6
JO - Giordania 6
KG - Kirghizistan 6
KZ - Kazakistan 6
BE - Belgio 5
CR - Costa Rica 5
DZ - Algeria 5
LT - Lituania 5
PS - Palestinian Territory 5
SN - Senegal 5
HN - Honduras 4
PR - Porto Rico 4
GE - Georgia 3
HR - Croazia 3
HU - Ungheria 3
MO - Macao, regione amministrativa speciale della Cina 3
NG - Nigeria 3
NP - Nepal 3
NZ - Nuova Zelanda 3
RS - Serbia 3
UY - Uruguay 3
AL - Albania 2
AM - Armenia 2
AO - Angola 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
GH - Ghana 2
GT - Guatemala 2
NI - Nicaragua 2
OM - Oman 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
UG - Uganda 2
AZ - Azerbaigian 1
BB - Barbados 1
BJ - Benin 1
BN - Brunei Darussalam 1
BW - Botswana 1
BY - Bielorussia 1
CG - Congo 1
Totale 14.116
Città #
Ann Arbor 819
Singapore 802
Hong Kong 610
Frankfurt am Main 530
Ashburn 420
San Jose 344
Ho Chi Minh City 339
Milan 319
Fairfield 259
Hanoi 250
Wilmington 213
Toronto 198
Dublin 167
Dallas 161
Santa Clara 160
Houston 147
New York 146
Hefei 126
Chicago 124
Chandler 116
Los Angeles 115
Seattle 108
Beijing 100
The Dalles 96
Rome 94
Woodbridge 94
Princeton 89
Jakarta 86
Cambridge 78
Lauterbourg 61
Moscow 56
Dearborn 54
Dong Ket 49
Seoul 49
Altamura 45
Shanghai 44
Lawrence 43
San Diego 40
Helsinki 38
Buffalo 35
Da Nang 35
Guangzhou 35
Nanjing 32
Council Bluffs 31
Haiphong 31
Biên Hòa 30
Boardman 29
São Paulo 29
Ha Long 27
Munich 27
Naples 24
Tokyo 24
Nuremberg 23
Columbus 22
Turin 22
Warsaw 20
Jacksonville 19
Sacramento 19
Atlanta 18
Hải Dương 18
London 18
Montreal 18
Thái Nguyên 18
Zurich 17
Ardea 16
Quận Bình Thạnh 16
Mumbai 15
Dhaka 14
Andover 13
Chennai 13
Kent 13
Orem 13
Quận Một 13
Vienna 13
Bologna 12
Brooklyn 12
Lappeenranta 12
Monza 12
Rio de Janeiro 12
Seregno 12
Umeå 12
Baghdad 11
Carate Brianza 11
Figino 11
Hangzhou 11
Miami 11
Paris 11
Phoenix 11
Salt Lake City 11
Sesto San Giovanni 11
Addis Ababa 10
Belo Horizonte 10
Brasília 10
Brescia 10
Denver 10
Jeddah 10
Johannesburg 10
Pune 10
Bắc Giang 9
Ninh Bình 9
Totale 8.630
Nome #
Joinpoint regression analysis with time-on-study as time-scale. Application to three Italian population-based cohort studies 619
Outcomes of patients with advanced solid tumors who discontinued immune-checkpoint inhibitors: a systematic review and meta-analysis 517
Laryngeal cancer mortality trends in European countries 382
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes 374
Male breast cancer: a multicenter study to provide a guide for proper management 355
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study 350
Efficacy and Limitations of Quinidine in Patients with Brugada Syndrome 316
Surrogate endpoints for overall survival in randomized clinical trials testing immune checkpoint inhibitors: a systematic review and meta-analysis 312
Sex-based differences of the Tumor mutational burden and T-cell inflammation of the tumor microenvironment 286
Fertility concerns, preservation strategies and quality of life in young women with breast cancer: Baseline results from an ongoing prospective cohort study in selected European Centers 280
Sentinel lymph node biopsy in microinvasive ductal carcinoma in situ 280
Pre-operative evaluation of epithelial ovarian cancer patients: Role of whole body diffusion weighted imaging MR and CT scans in the selection of patients suitable for primary debulking surgery. A single-centre study 273
Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp-cooling system in early breast cancer patients treated with anthracyclines 271
"Heterogeneity of treatment effect on patients' long-term outcome according to pathological response type in neoadjuvant RCTs for breast cancer." 268
Prognostic and predictive value of cell cycle progression (CCP) score in ductal carcinoma in situ of the breast 267
Effectiveness of intensive clinical and radiological follow-up in patients with surgically resected NSCLC. Analysis of 2661 patients from the prospective MAGRIT trial 264
Sex-Based Heterogeneity in Response to Lung Cancer Immunotherapy: A Systematic Review and Meta-Analysis 236
Evaluation of pathological complete response as surrogate endpoint in neoadjuvant randomised clinical trials of early stage breast cancer: systematic review and meta-analysis 224
Sex-based differences in cancer immunotherapy efficacy 222
Endocrine-responsive lobular carcinoma of the breast: Features associated with risk of late distant recurrence 220
Surrogate End Points for Overall Survival in Neoadjuvant Randomized Clinical Trials for Early Breast Cancer 217
Tailoring the optimal duration of the extended adjuvant endocrine therapy in patients with early-stage breast cancer. A systematic review and meta-analysis of randomized clinical trials 216
Employment trajectories of young women with breast cancer: an ongoing prospective cohort study in Italy and Switzerland 216
Hydroquinidine Prevents Life-Threatening Arrhythmic Events in Patients With Short QT Syndrome 210
Metronomic Chemotherapy for First-Line Treatment of Metastatic Triple-Negative Breast Cancer: A Phase II Trial 210
Shifting from axillary dissection to targeted axillary surgery after neoadjuvant treatment: the evolving management of occult breast cancer in a monoinstitutional series of 114 patients 207
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1 205
Reply to Comments on: “Preventing chemotherapy-induced alopecia: a prospective clinical trial on the efficacy and safety of a scalp cooling system in early breast cancer patients treated with anthracyclines.” 205
Association of prebiotic fiber intake with colorectal cancer risk: the PrebiotiCa study 202
Assessment of absolute risk of life-threatening cardiac events in long QT syndrome patients 200
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up 198
Comparative Efficacy of Classic Versus Horizontal Incision Techniques in Skin-Reducing Mastectomy: A Single Center Retrospective Analysis 197
Surrogate endpoints for overall survival in randomized clinical trials testing antibody-drug conjugates 195
Development and Validation of a Natural Language Processing Algorithm for Extracting Clinical and Pathological Features of Breast Cancer From Pathology Reports 194
Diagnostic performance of image-guided vacuum-assisted breast biopsy after neoadjuvant therapy for breast cancer: prospective pilot study 191
Sex-based dimorphism of anticancer immune response and molecular mechanisms of immune evasion 187
Prognosis of selected triple negative apocrine breast cancer patients who did not receive adjuvant chemotherapy 186
The prolonged clinical benefit with metronomic chemotherapy (VEX regimen) in metastatic breast cancer patients 185
Results of the Italian cross-sectional web-based survey “Nutrition and breast cancer, what would you like to know?” An attempt to collect and respond to patients’ information needs, through social media 180
Multicomponent interventions and technologies to reduce the burden of frailty, functional, and cognitive decline: insights from the Age-It Research Program 177
Epidermal growth factor receptor detection in serum and saliva as a diagnostic and prognostic tool in oral cancer 176
Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer 172
Interplay Between Genetic Substrate, QTc Duration, and Arrhythmia Risk in Patients With Long QT Syndrome 168
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy 168
Evaluation of endocrine therapy and patients preferences in early breast cancer: results of Elena study 164
Different Response to Immunotherapy According to Melanoma Histologic Subtype 164
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer? 161
How to Perform Repeat Sentinel Node Biopsy Safely After a Previous Mastectomy: Technical Features and Oncologic Outcomes 157
Prognostic impact of baseline immunologic profile in aggressive b-cell non-hodgkin's lymphomas 156
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk) 153
Value of 3D echocardiography in the diagnosis of arrhythmogenic right ventricular cardiomyopathy 151
Intra- inter-observer repeatability in liver computed tomography volumetry in patients undergoing radioembolization simulation 149
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance? 147
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis 143
Pegylated liposomal doxorubicin (Caelyx®) as adjuvant treatment in early-stage luminal b-like breast cancer: A feasibility phase II trial 141
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations 129
Systematic review and meta-analysis of post-progression outcomes in ER+/HER2− metastatic breast cancer after CDK4/6 inhibitors within randomized clinical trials 127
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 126
Ductal carcinoma in situ of the male breast: clinical radiological features and management in a cancer referral center 126
Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk): comment - Authors' reply 125
Sex-based differences in response to anti-PD-1 or PD-L1 treatment in patients with non-small-cell lung cancer expressing high PD-L1 levels. A systematic review and meta-analysis of randomized clinical trials 121
Outcome of patients with metastatic triple negative breast cancer treated with first-line chemotherapy: a single institution retrospective analysis 117
Adjuvant treatment for triple negative breast cancer with residual tumor after neo-adjuvant chemotherapy. A single institutional retrospective analysis 117
Improved outcomes in women with BRAF-mutant melanoma treated with BRAF/MEK-targeted therapy across randomized clinical trials. A systematic review and meta-analysis 115
Heterogeneity of progression-free survival surrogacy by sex in randomized trials testing immunotherapy in non-small cell lung cancer 111
One-Year Mortality in Hospitalized, Frail Older Adults with Atrial Fibrillation on Oral Anticoagulant Therapy: Impact of Stroke and Bleeding Events 107
Outcomes, indications and predictive factors for complications in postmastectomy prepectoral reconstructions with polyurethane foam-coated implants 105
Comparison of Trends in Mortality from Coronary Heart and Cerebrovascular Diseases in North and South America: 1980 to 2013 104
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment 100
Distant disease-free survival as a surrogate endpoint for overall survival in randomised trials of neoadjuvant therapy for early breast cancer: a pooled analysis of GBG and AGO-B Study Group trials 82
Extended Endocrine Therapy Following 5 Years of Adjuvant Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal Patients With Node-Positive, Hormone Receptor–Positive Breast Cancer: A Cohort Study 77
Effect of a Multimedia-Assisted Informed Consent Procedure on the Information Gain of Patients Undergoing Mastectomy and Implant-Based Reconstruction 68
Effects of multidomain interventions on health outcomes in older adults: A systematic review and meta-analysis 38
Totale 14.559
Categoria #
all - tutte 49.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 49.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022661 0 52 63 33 24 72 33 45 46 79 70 144
2022/20231.251 149 352 172 105 102 185 29 34 24 34 32 33
2023/2024776 18 15 29 72 79 158 106 46 72 40 31 110
2024/20252.649 129 306 135 132 159 138 164 93 296 329 307 461
2025/20266.723 846 772 520 575 544 261 818 325 437 521 511 593
2026/2027286 280 6 0 0 0 0 0 0 0 0 0 0
Totale 14.559